{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:51:39Z","timestamp":1774407099934,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"DOI":"10.7759\/cureus.105794","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:54:34Z","timestamp":1774403674000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Intravitreal Ranibizumab on Retinopathy of Prematurity: A Retrospective Analysis"],"prefix":"10.7759","author":[{"given":"Fumihiko","family":"Nitta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kunikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe H","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013, 74:35-49. 10.1038\/pr.2013.205","journal-title":"Pediatr Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00744-7","article-title":"Laser versus anti-VEGF: a paradigm shift for treatment-warranted retinopathy of prematurity","volume":"12","author":"Hartnett ME","year":"2023","unstructured":"Hartnett ME, Stahl A. Laser versus anti-VEGF: a paradigm shift for treatment-warranted retinopathy of prematurity. Ophthalmol Ther. 2023, 12:2241-52. 10.1007\/s40123-023-00744-7","journal-title":"Ophthalmol Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2019.05.011","article-title":"Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity","volume":"43","author":"VanderVeen DK","year":"2019","unstructured":"VanderVeen DK, Cataltepe SU. Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity. Semin Perinatol. 2019, 43:375-80. 10.1053\/j.semperi.2019.05.011","journal-title":"Semin Perinatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology","volume":"124","author":"VanderVeen DK","year":"2017","unstructured":"VanderVeen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR. Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology. Ophthalmology. 2017, 124:619-33. 10.1016\/j.ophtha.2016.12.025","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2008.1","article-title":"Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study","volume":"126","author":"Kong L","year":"2008","unstructured":"Kong L, Mintz-Hittner HA, Penland RL, Kretzer FL, Ch\u00e9vez-Barrios P. Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study. Arch Ophthalmol. 2008, 126:1161-3. 10.1001\/archophthalmol.2008.1","journal-title":"Arch Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International Classification of Retinopathy of Prematurity, Third Edition","volume":"128","author":"Chiang MF","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, et al.. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology. 2021, 128:e51-68. 10.1016\/j.ophtha.2021.05.031","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","unstructured":"Revised indications for the treatment of retinopathy of prematurity. results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003, 121:1684-94. 10.1001\/archopht.121.12.1684","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-011-1021-z","article-title":"Laser treatment for retinopathy of prematurity","volume":"28","author":"Houston SK","year":"2013","unstructured":"Houston SK, Wykoff CC, Berrocal AM, Hess DJ, Murray TG. Laser treatment for retinopathy of prematurity. Lasers Med Sci. 2013, 28:683-92. 10.1007\/s10103-011-1021-z","journal-title":"Lasers Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2021.00773","article-title":"Retinopathy of prematurity: a review of epidemiology and current treatment strategies","volume":"65","author":"Hong EH","year":"2022","unstructured":"Hong EH, Shin YU, Cho H. Retinopathy of prematurity: a review of epidemiology and current treatment strategies. Clin Exp Pediatr. 2022, 65:115-26. 10.3345\/cep.2021.00773","journal-title":"Clin Exp Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-022-00921-4","article-title":"Risk factors for early-onset high myopia after treatment for retinopathy of prematurity","volume":"66","author":"Matsumura S","year":"2022","unstructured":"Matsumura S, Matsumoto T, Katayama Y, et al.. Risk factors for early-onset high myopia after treatment for retinopathy of prematurity. Jpn J Ophthalmol. 2022, 66:386-93. 10.1007\/s10384-022-00921-4","journal-title":"Jpn J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279898","article-title":"Association between myopia progression and quantity of laser treatment for retinopathy of prematurity","volume":"17","author":"Hwang ES","year":"2022","unstructured":"Hwang ES, Kassem IS, Allozi R, Kravets S, Al-Kirwi KY, Hallak JA, Costakos DM. Association between myopia progression and quantity of laser treatment for retinopathy of prematurity. PLoS One. 2022, 17:e0279898. 10.1371\/journal.pone.0279898","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-01321-z","article-title":"Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity","volume":"35","author":"Mori Y","year":"2021","unstructured":"Mori Y, Arima M, Ueda E, et al.. Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity. Eye (Lond). 2021, 35:2820-5. 10.1038\/s41433-020-01321-z","journal-title":"Eye (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.229","article-title":"Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity study","volume":"129","author":"Repka MX","year":"2011","unstructured":"Repka MX, Tung B, Good WV, Capone A Jr, Shapiro MJ. Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol. 2011, 129:1175-9. 10.1001\/archophthalmol.2011.229","journal-title":"Arch Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032416","article-title":"Long-term visual prognosis of patients following lens-sparing vitrectomy for Stage 4A retinopathy of prematurity","volume":"24","author":"Iwahashi C","year":"2023","unstructured":"Iwahashi C, Kurihara T, Kuniyoshi K, Kusaka S. Long-term visual prognosis of patients following lens-sparing vitrectomy for Stage 4A retinopathy of prematurity. Int J Mol Sci. 2023, 24:2416. 10.3390\/ijms24032416","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.12.028","article-title":"Retinal detachment after treatment of retinopathy of prematurity with laser versus intravitreal anti-vascular endothelial growth factor","volume":"128","author":"Barry GP","year":"2021","unstructured":"Barry GP, Yu Y, Ying GS, Tomlinson LA, Lajoie J, Fisher M, Binenbaum G. Retinal detachment after treatment of retinopathy of prematurity with laser versus intravitreal anti-vascular endothelial growth factor. Ophthalmology. 2021, 128:1188-96. 10.1016\/j.ophtha.2020.12.028","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-025-01157-4","article-title":"Systemic effects of intravitreal anti-VEGF therapy: a review of safety across organ systems","volume":"14","author":"Banerjee M","year":"2025","unstructured":"Banerjee M, Moharana S, Padhy SK. Systemic effects of intravitreal anti-VEGF therapy: a review of safety across organ systems. Ophthalmol Ther. 2025, 14:1661-84. 10.1007\/s40123-025-01157-4","journal-title":"Ophthalmol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384263-impact-of-intravitreal-ranibizumab-on-retinopathy-of-prematurity-a-retrospective-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:54:35Z","timestamp":1774403675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384263-impact-of-intravitreal-ranibizumab-on-retinopathy-of-prematurity-a-retrospective-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.105794","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}